[1] DELARA M, CHAUHAN BF, LE ML, et al. Efficacy and safety of pulmonary application of corticosteroids in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis[J]. Arch Dis Child Fetal Neonatal Ed, 2019, 104(2): F137. doi: 10.1136/archdischild-2017-314046
[2] PRINCIPI N, DI PIETRO GM, ESPOSITO S. Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies[J]. J Transl Med, 2018, 16(1): 36. doi: 10.1186/s12967-018-1417-7
[3] BASSLER D, SHINWELL ES, HALLMAN M, et al. Long-term effects of inhaled budesonide for bronchopulmonary dysplasia[J]. N Engl J Med, 2018, 378(2): 148. doi: 10.1056/NEJMoa1708831
[4] SHINWELL ES. Are inhaled steroids safe and effective for prevention or treatment of bronchopulmonary dysplasia?[J]. Acta Paediatr, 2018, 107(4): 554. doi: 10.1111/apa.14180
[5] SHAH VS, OHLSSON A, HALLIDAY HL, et al. Early administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates[J]. Cochrane Database Syst Rev, 2017, 1(1): CD001969.
[6] SWEET DG, CARNIELLI V, GREISEN G, et al. European Consensus Guidelines on the Management of Respiratory Distress Syndrome-2019 Update[J]. Neonatology, 2019, 115(4): 432. doi: 10.1159/000499361
[7] 黄智峰, 李欢, 黄鹏, 等. 早期雾化吸入布地奈德预防极低出生体质量儿支气管肺发育不良[J]. 中国实用儿科临床杂志, 2018, 32(2): 117.
[8] 苏衡. 布地奈德混悬液氧驱雾化吸人防治早产儿支气管肺发育不良的临床效果[J]. 国际医药卫生导报, 2016, 22(14): 2128. doi: 10.3760/cma.j.issn.1007-1245.2016.14.037
[9] 王耀霜, 杨曼, 韩萍. 等. 布地奈德混悬液氧驱雾化吸入法防治早产儿支气管肺发育不良的效果[J]. 临床和实验医学杂志, 2019, 18(19): 2121. doi: 10.3969/j.issn.1671-4695.2019.19.032
[10] 王亚洲, 张笃飞. 布地奈德持续雾化吸入联合肺表面活性物质对新生儿呼吸窘迫综合征的临床疗效分析[J]. 现代医学, 2018, 46(11): 1243. doi: 10.3969/j.issn.1671-7562.2018.11.010
[11] 郑敏斯. 探讨布地奈德持续雾化吸入联合肺表面活性物质治疗新生儿呼吸窘迫综合征(RDS)对支气管肺发育不良的影响[J]. 北方药学, 2019, 16(9): 41. doi: 10.3969/j.issn.1672-8351.2019.09.028
[12] 张会敏. 布地奈德持续雾化吸入联合肺表面活性物质治疗新生儿呼吸窘迫综合征的临床疗效分析[J]. 现代诊断与治疗, 2019, 30(8): 1281.
[13] 黄进洁, 闫玉琴, 李志光, 等. 布地奈德防治早产儿支气管肺发育不良的临床研究[J]. 中国临床药理学杂志, 2020, 36(4): 390.
[14] 齐骥, 卓龙冉, 刘洁. 不同给药方式应用糖皮质激素治疗支气管肺发育不良患儿的临床研究[J]. 中国妇幼保健, 2019, 34(23): 5439.
[15] KOVÁCS L, DAVIS GM, FAUCHER D, et al. Efficacy of sequential early systemic and inhaled corticosteroid therapy in the prevention of chronic lung disease of prematurity[J]. Acta Paediatr, 1998, 87(7): 792. doi: 10.1111/j.1651-2227.1998.tb01749.x
[16] JÓNSSON B, ERIKSSON M, SÖDER O, et al. Budesonide delivered by dosimetric jet nebulization to preterm very low birthweight infants at high risk for development of chronic lung disease[J]. Acta Paediatr, 2000, 89(12): 1449. doi: 10.1111/j.1651-2227.2000.tb02775.x
[17] 申昆玲, 邓力, 李云珠, 等. 糖皮质激素雾化吸入疗法在儿科应用的专家共识(2018年修订版)[J]. 临床儿科杂志, 2018, 36(2): 95. doi: 10.3969/j.issn.1000-3606.2018.02.004
[18] YEH TF, LIN HC, CHANG CH, et al. Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: a pilot study[J]. Pediatrics, 2008, 121(5): e1310. doi: 10.1542/peds.2007-1973
[19] BASSLER D, PLAVKA R, SHINWELL ES, et al. Early inhaled budesonide for the prevention of bronchopulmonary dysplasia[J]. N Engl J Med, 2015, 373(16): 1497. doi: 10.1056/NEJMoa1501917
[20] JOBE AH, BANCALARI E. Bronchopulmonary dysplasia[J]. Am J Respir Crit Care Med, 2001, 163(7): 1723. doi: 10.1164/ajrccm.163.7.2011060
[21] SWEET DG, CARNIELLI V, GREISEN G, et al. European Consensus Guidelines on the Management of Respiratory Distress Syndrome-2016 Update[J]. Neonatology, 2017, 111(2): 107. doi: 10.1159/000448985
[22] CERNADA M, BRUGADA M, GOLOMBEK S, et al. Ventilator-associated pneumonia in neonatal patients: an update[J]. Neonatology, 2014, 105(2): 98. doi: 10.1159/000355539
[23] NOVAK CM, OZEN M, BURD I. Perinatal brain injury: mechanisms, prevention, and outcomes[J]. Clin Perinatol, 2018, 45(2): 357. doi: 10.1016/j.clp.2018.01.015
[24] HEIDA FH, STOLWIJK L, LOOS MH, et al. Increased incidence of necrotizing enterocolitis in the Netherlands after implementation of the new Dutch guideline for active treatment in extremely preterm infants: Results from three academic referral centers[J]. J Pediatr Surg, 2017, 52(2): 273. doi: 10.1016/j.jpedsurg.2016.11.024
[25] International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited[J]. Arch Ophthalmol, 2005, 123(7): 991. doi: 10.1001/archopht.123.7.991
[26] BENITZ WE, Committee on Fetus and Newborn, American Academy of Pediatrics. Patent ductus arteriosus in preterm infants[J]. Pediatrics, 2016, 137(1).
[27] 中华医学会儿科学分会新生儿学组, 中国医师协会新生儿科医师分会感染专业委员会. 新生儿败血症诊断及治疗专家共识(2019年版)[J]. 中华儿科杂志, 2019, 57(4): 252. doi: 10.3760/cma.j.issn.0578-1310.2019.04.005
[28] DIONNE JM, FLYNN JT. Management of severe hypertension in the newborn[J]. Arch Dis Child, 2017, 102(12): 1176. doi: 10.1136/archdischild-2015-309740
[29] HAY WW JR, ROZANCE PJ. Neonatal hyperglycemia-causes, treatments, and cautions[J]. J Pediatr, 2018, 200: 6. doi: 10.1016/j.jpeds.2018.04.046
[30] 李盼盼, 赵武. 早产儿支气管肺发育不良定义演变及流行病学特征[J]. 中华新生儿科杂志, 2020, 35(5): 385. doi: 10.3760/cma.j.issn.2096-2932.2020.05.019
[31] 早产儿支气管肺发育不良调查协作组. 早产儿支气管肺发育不良发生率及高危因素的多中心回顾调查分析[J]. 中华儿科杂志, 2011, 49(9): 655. doi: 10.3760/cma.j.issn.0578-1310.2011.09.004
[32] 张明霞, 赵瑞卿, 李庆霞, 等. 早产儿支气管肺发育不良的影响因素分析[J]. 蚌埠医学院学报, 2017, 42(10): 1321.
[33] NORTHWAY WH JR, ROSAN RC, PORTER DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia[J]. N Engl J Med, 1967, 276(7): 357. doi: 10.1056/NEJM196702162760701
[34] HIGGINS RD, JOBE AH, KOSO-THOMAS M, et al. Bronchopulmonary dysplasia: executive summary of a workshop[J]. J Pediatr, 2018, 197: 300. doi: 10.1016/j.jpeds.2018.01.043